These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 6187823)
1. Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen. Liang-Takasaki CJ; Grossman N; Leive L J Immunol; 1983 Apr; 130(4):1867-70. PubMed ID: 6187823 [TBL] [Abstract][Full Text] [Related]
2. Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen length. Grossman N; Leive L J Immunol; 1984 Jan; 132(1):376-85. PubMed ID: 6197450 [TBL] [Abstract][Full Text] [Related]
3. Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. Liang-Takasaki CJ; Mäkelä PH; Leive L J Immunol; 1982 Mar; 128(3):1229-35. PubMed ID: 6120195 [TBL] [Abstract][Full Text] [Related]
4. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages. Mosser DM; Edelson PJ J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545 [TBL] [Abstract][Full Text] [Related]
5. C3b binding, but not its breakdown, is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from Salmonellae. Grossman N; Joiner KA; Frank MM; Leive L J Immunol; 1986 Mar; 136(6):2208-15. PubMed ID: 3950413 [TBL] [Abstract][Full Text] [Related]
6. Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation. Schorlemmer HU; Bitter-Suermann D; Allison AC Immunology; 1977 Jun; 32(6):929-40. PubMed ID: 328387 [TBL] [Abstract][Full Text] [Related]
7. Enhanced alternative complement pathway-dependent degradation of soluble immunoglobulin aggregates by macrophages. Daha MR; Van Es LA Immunology; 1981 Jul; 43(3):513-8. PubMed ID: 7251062 [TBL] [Abstract][Full Text] [Related]
8. Alternative complement pathway activation by Salmonella O polysaccharide as a virulence determinant in the mouse. Saxén H; Reima I; Mäkelä PH Microb Pathog; 1987 Jan; 2(1):15-28. PubMed ID: 3333794 [TBL] [Abstract][Full Text] [Related]
9. Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae. Liang-Takasaki CJ; Saxén H; Mäkelä PH; Leive L Infect Immun; 1983 Aug; 41(2):563-9. PubMed ID: 6347890 [TBL] [Abstract][Full Text] [Related]
10. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement. Inada K Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130 [TBL] [Abstract][Full Text] [Related]
11. C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. Joiner KA; Grossman N; Schmetz M; Leive L J Immunol; 1986 Jan; 136(2):710-5. PubMed ID: 2416822 [TBL] [Abstract][Full Text] [Related]
12. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan. Schenkein HA; Ruddy S J Immunol; 1981 Jan; 126(1):7-10. PubMed ID: 6778918 [TBL] [Abstract][Full Text] [Related]
13. Conjugation of tetanus toxoid with Salmonella typhimurium PTCC 1735 O-specific polysaccharide and its effects on production of opsonizing antibodies in a mouse model. Jazani NH; Worobec E; Shahabi S; Nejad GB Can J Microbiol; 2005 Apr; 51(4):319-24. PubMed ID: 15980894 [TBL] [Abstract][Full Text] [Related]
14. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells. Svensson M; Pfeifer J; Stockinger B; Wick MJ Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741 [TBL] [Abstract][Full Text] [Related]
15. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation. Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569 [TBL] [Abstract][Full Text] [Related]
16. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni. Ferrante A; Rowan-Kelly B Clin Exp Immunol; 1983 Nov; 54(2):477-85. PubMed ID: 6418422 [TBL] [Abstract][Full Text] [Related]
17. [Activity of the alternative complement pathway by various axenic strains of Entamoeba histolytica]. Capin NR; Capin R; Zamacona G; Ortiz-Ortiz L Arch Invest Med (Mex); 1978; 9 Suppl 1():291-6. PubMed ID: 211963 [TBL] [Abstract][Full Text] [Related]
18. Effect of Haemophilus influenzae type b lipopolysaccharide on complement activation and polymorphonuclear leukocyte function. Inzana TJ; Tosi MF; Kaplan SL; Anderson DC; Mason EO; Williams RP Pediatr Res; 1987 Dec; 22(6):659-66. PubMed ID: 3324033 [TBL] [Abstract][Full Text] [Related]
19. Salmonella O antigen-specific oligosaccharide-octyl conjugates activate complement via the alternative pathway at different rates depending on the structure of the O antigen. Grossman N; Svenson SB; Leive L; Lindberg AA Mol Immunol; 1990 Sep; 27(9):859-65. PubMed ID: 1699120 [TBL] [Abstract][Full Text] [Related]